Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • Bitcoin USD

    64,392.51
    +1,524.65 (+2.43%)
     
  • CMC Crypto 200

    1,383.75
    +71.13 (+5.42%)
     
  • S&P 500

    4,971.93
    -39.19 (-0.78%)
     
  • Dow

    37,936.83
    +161.45 (+0.43%)
     
  • Nasdaq

    15,316.81
    -284.69 (-1.83%)
     
  • Gold

    2,410.40
    +12.40 (+0.52%)
     
  • Crude Oil

    83.14
    +0.41 (+0.50%)
     
  • 10-Yr Bond

    4.6230
    -0.0240 (-0.52%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Why PetMed Express Was a Dog of a Stock This Week

Why PetMed Express Was a Dog of a Stock This Week

While animal healthcare specialist PetMed Express (NASDAQ: PETS) advertises itself as "your trusted pet expert," the stock market wasn't trusting it as a solid investment this week. According to data compiled by S&P Global Market Intelligence, the company's shares fell by 13% for the week, largely due to its lackluster quarterly results. In the third quarter of its fiscal 2023, PetMed Express booked $58.9 million in net sales, a slight drop from the $60.7 million it made in the same quarter of the previous fiscal year.